CAS: 7246-21-1; Sodium 2-(3-Butyramido-2,4,6-Triiodobenzyl)Butanoate

英文名称Sodium 2-(3-Butyramido-2,4,6-Triiodobenzyl)Butanoate
中文名称酪泮酸钠
IUPAC名称sodium 2-(3-butyramido-2,4,6-triiodobenzyl)butanoate
其它别名3-Butyramido-Alpha-Ethyl-2,4,6-Triiodohydrocinnamicacidsodiumsalt; Sodiumtyropanoate; Tyropanoatesodium; Tyropaque; Tyropanoic Acid Sodium Salt; 3-Butyrylamino-α-Ethyl-2,4,6-Triiodohydrocinnamic Acid Sodium
CAS编号7246-21-1
MFCD编号:MFCD01722213
EINECS号:230-653-9
FDA UNII编号:XRJ0P5FAYO
分子式:C15H17I3NNaO3分子量:663.01
产品CID: 1709494
同类组份化合物CAS7246-21-1 (sodium)27293-82-9 (acid)
产品分类有机原料 → 苯丙烷和聚酮 → 苯丙酸

相似结构搜索
InChIKey: KTVKGXZZBQCBGD-UHFFFAOYNA-M
InChI=1S/C15H18I3NO3.Na/c1-3-5-12(20)19-14-11(17)7-10(16)9(13(14)18)6-8(4-2)15(21)22;/h7-8H,3-6H2,1-2H3,(H,19,20)(H,21,22);/q;+1/p-1
计算化学: 氢键受体数3.0氢键供体数2.0可旋转键数7.0

MSDS等安全信息

警示词warning
危险描述H303 May be harmful if swallowed+H313 Skin contact may be harmful+H333 Inhalation may be harmful to the body
防范说明P264Thoroughly clean after treatmentP280Wear protective gloves/Wear protective clothing/Wear protective goggles/Wear a protective maskP305If it enters the eyesP351Rinse carefully with water for a few minutesP338Remove the contact lens(If any)And easy to operate,Continue flushingP337If eye irritation persistsP313Obtain medical advice/care
安全声明H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
危险类别码R36/37/38:对眼睛,呼吸道和皮肤有刺激作用.

合成工艺路线路线简述

海关参考信息

2902600000-乙苯
2905121000-正丙醇
2912110000-甲醛
2912120000-乙醛
💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
详情请参考：📖 海关编码查询和海关进出口税则

专利信息

专利号:US-2011104052-A1
优先权日:2007-12-03
标题 :Methods of synthesis and use of chemospheres
发明人：BARNETT BRADLEY POWERS; GESCHWIND JEFFREY
权利人:UNIV JOHNS HOPKINS
摘要:The present invention provides, in general, compositions comprising a hydrogel and an agent, for example a therapeutic agent or an imaging agent, for locoregional delivery. In certain preferred embodiments of the invention, the hydrogel compositions are detectable by Magnetic Responance and CT Scan and are used for locoregional delivery of therapeutic agents, for example chemotherapeutic agents. The invention also features polymer matrix compositions comprising nanoparticles that can be loaded after polymerization with bioactive agents, for example a diagnostic agent or therapeutic agent.

专利号:US-2014315720-A1
优先权日:2012-10-24
标题 :Polysaccharide ester microspheres and methods and articles relating thereto
发明人：FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY
权利人:CELANESE ACETATE LLC
摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.

专利号:EP-2229147-A2
优先权日:2007-12-03
标题 :Methods of synthesis and use of chemospheres

专利号:WO-2009073193-A2
优先权日:2007-12-03
标题 :Methods of synthesis and use of chemospheres